Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Anal Chem. 2009 Oct 1;81(19):8141–8149. doi: 10.1021/ac9013644

Figure 2.

Figure 2

Dose Response plots for human insulin B-Chain peptide 23-29. The experimental curves (blue) from two sets of experiments fit to the first order theoretical curves (red) corresponding to a rate constant of 8.14 for monomeric form versus 4.61 for the hexamer. Lower rate constant for the hexamer indicates the reduced solvent accessibility for the peptide.